PTPRC and experimental autoimmune encephalomyelitis: Furthermore, administration of the FGFR inhibitor infigratinib in a mouse model of experimental autoimmune encephalomyelitis reduces infiltration of CD3+ T cells, B220+ B cells, and activated microglia in the spinal cord (Rajendran et al., 2023).